IndraLab
Statements
reach
"These results provide rationale for the use of cabozantinib in treatment of patients with cancers harboring p53-Y220C mutant.We show that USP7, a deubiquitinase type involved in the stabilization and removal of lysine-linked ubiquitin from various substrate proteins, physically interacts with p53 protein (Fig. 4A) and facilitates the deubiquitination and stabilization of p53 protein (Fig. 4D and Fig. S5A), and cabozantinib can inhibit the interaction between USP7 and p53 , resulting in decreased ubiquitination and amount of p53 protein (Fig. 4)."
sparser
"As depicted in xref D, endogenous HAUSP clearly interacted with endogenous epitope-tagged p53 in HCT116 cells, demonstrating the functional integrity of the epitope-tagged allele of p53 and providing proof-of-principle for the use of cells with endogenous epitope-tagged alleles for the confirmation of endogenous protein–protein interactions."
reach
"Although the effects of HAUSP on p53, Mdm2, and MdmX presumably occurs in the nucleus, HAUSP localizes to both the nucleus and cytoplasm, and mitochondrial HAUSP has been shown to deubiquitinate a cytoplasmic pool of monoubiquitinated p53 upon arriving at the mitochondria through a stress induced p53 and HAUSP complex, which thereby creates a sub-fraction of non ubiquitinated p53 that can induce transcription independent apoptosis [XREF_BIBR]."
sparser
"The hyperubiquitylation of p53 in neuroblastoma proposed in this model is not caused by MDM2 (E3 ligase) overexpression and/or herpesvirus-associated ubiquitin-specific protease (HAUSP) (p53-deubiquitylating enzyme) downregulation, but due to an impaired p53-HAUSP interaction [ xref ]."
sparser
"TSPYL5 is a poor prognostic factor for breast cancer and interacts with HAUSP to impair the HAUSP-p53 interaction, suppressing p53 function and resulting in enhanced cell proliferation. xref This action is functionally similar to that previously reported for the viral-protein EBNA1, which competitively inhibits HAUSP-p53 complex formation. xref "
sparser
"The N-terminal region of Bat3 containing an ubiquitin-linked domain was found to have capacity to form a stable complex with both HAUSP ( xref , lane 3) and p53 ( xref , lane 3), but other deletions, which are lacking the N-terminus, completely abolish the ability to form complexes ( xref , lanes 4 and 5; xref , lanes 5 and 6)."
sparser
"So, vIRF-4 can interfere with p53-HAUSP Mdm2 to break the cell cycle pause and apoptosis activation by p53 and all together promote uncontrolled cell proliferation and transformation in host cells. xref The tegument protein ORF-64 of KSHV is a viral cysteine protease with DUB activity that interacts with IFN signaling."
sparser
"Our findings highlighted the essential role of nuclear PFKFB3 dysfunction and USP7-p53 axis dysregulation in mediating EC senescence under diabetic stress, suggesting that targeting PFKFB3 nuclear translocation may be a novel therapeutic strategy for the prevention of diabetic retinopathy."
reach
"However, the identification of a complex of TSPY1, USP7, and p53 suggested that unlike the binding of TSPYL5 with USP7, the binding of TSPY1 to USP7 did not exclude the binding of USP7 to p53, which was supported by the finding that TSPY1 could interact with non-p53-specific binding domains of USP7."
sparser
"We show that USP7, a deubiquitinase type involved in the stabilization and removal of lysine-linked ubiquitin from various substrate proteins, physically interacts with p53 Y220C protein ( xref A ) and facilitates the deubiquitination and stabilization of p53 Y220C protein ( xref D and xref A ), and cabozantinib can inhibit the interaction between USP7 and p53 Y220C , resulting in decreased ubiquitination and amount of p53 Y220C protein ( xref )."
reach
"From a mechanistic perspective, upon activation, TP53 binds directly to the SLC7A11 promoter or interacts with ubiquitin-specific peptidase 7, reducing histone H2B monoubiquitination on the promoter, thus decreasing SLC7A11 expression and lessening cysteine uptake (thereby decreasing GSH synthesis), which promotes ferroptosis [51–53]."
reach
"Some DUBs have additional binding sites with affinity for the target protein that is ubiquitylated (Ventii and Wilkinson, 2008) ; for example, USP7 binds to a peptide sequence present in its substrates p53, MDM2 (murine double minute 2, an oncoprotein) and the Epstein Barr nuclear antigen-1 (Hu et al., 2006) ."
sparser
"This somewhat surprising finding suggested to us that the functional significance of the USP7-p53 axis in Ewing Sarcoma, and perhaps cancer more broadly, is not completely understood and that improved research tools are needed to enable reliable on-target analysis of USP7 biology."
sparser
"These include: (1) TRAF4-Akt/NF-κB-Glut1/HK2/RSK4/Slug in the proliferation and metastasis of lung and breast cancer cells as well as the migration and epithelial-mesenchymal transition (EMT) of hepatocellular carcinoma cells (HCC) ( xref , xref , xref ); (2) TGFβ-TβRI-TRAF4-Smurf1/Smurf2/USP15-SMAD2/TAK1-N-cadherin/Fibronectin/Vimentin/SMA in the migration, EMT, and metastasis of breast cancer cells ( xref , xref ); (3) SRC3-TRAF4-mediated inhibition of the USP7-p53 interaction, leading to the loss of p53 deubiquitination/stabilization and thus the resistance to cytotoxic drugs and stress in breast cancer ( xref ); (4) NGF-TrkA-TRAF4-Akt/p38-IL-6/Integrins/COX2 in the metastasis of prostate cancer cells ( xref ); (5) TNFα-TRAF4/TRAF2-NF-κB1 in the survival and proliferation of breast cancer cells ( xref ); (6) TRAF4-mediated up-regulation and nuclear translocation of β-catenin in the Wnt/β-catenin-cyclin D1/c-myc/Bcl-2/MMPs pathway that promote the growth and migration of OSCC and breast cancer cells ( xref , xref ); (7) TRAF4-mTOR-p70S6K-S6 in the proliferation of breast cancer cells ( xref ); and (8) the TRAF4-phosphoinositide (PIP) interaction at tight junctions that favors breast cancer cell migration ( xref )."
sparser
"A number of proteins have been reported to interact with USP7 and regulate its activity toward Mdm2 or p53. [ xref ] For instance, death domain associated protein (Daxx) promotes the binding of USP7 to Mdm2 and enhances Mdm2‐dependent p53 degradation. [ xref ] In addition, testis‐specific protein Y‐encoded like 5 (TSPYL5) and Epstein‐Barr virus nuclear antigen 1 (EBNA1) compete with p53 for binding to the TRAF‐like domain of USP7, thereby suppressing the function of p53. [ xref , xref ] Moreover, Abraxas brother 1 (ABRO1) stabilizes p53 by facilitating the interaction of p53 with USP7. [ xref ] In this study, we show that MLF2 binds to both N‐terminal TRAF‐like domain and C‐terminal UBL4‐5 of USP7."
sparser
"For example, while the wild-type p53 (residues 325–367) formed a stable complex with HAUSP (residues 53–206) as judged by their co-elution on gel filtration ( xref A, upper-right panel), the mutant p53 (S362A) and HAUSP (residues 53–206) did not interact with each other ( xref A, lower-right panel)."
sparser
"Since the p53 regulatory region contributes to DNA interactions by increasing the sliding of p53 on DNA and such sliding has been suggested to result in decreased detectable binding to short DNA fragments (such as used in our in vitro studies), it is likely that USP7 interactions with p53 C-terminal sequences result in decreased DNA sliding xref ."
reach
"Together, these data suggest that MLF2 reduces the binding of USP7 to p53 and thus attenuates USP7‐mediated deubiquitination of p53, resulting in the destabilization of p53.To further determine whether MLF2 regulates the p53 response to DNA damage, HCT116 cells with knockdown or overexpression of MLF2 were treated with the DNA‐damage‐inducing agent doxorubicin."
reach
"Since these two USP7 regions are also important for p53 binding,
21
,
25
,
42
it is reasonable that MLF2 may disrupt the interaction between USP7 and p53 in a competitive manner.MLF2 belongs to the myeloid leukemia factor family, which is involved in myelodysplastic syndrome and acute myeloid leukemia."